SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C195 - Stroke Team Action Therapy (STAT): Current State of the Art and New Frontiers

Event Time: Thursday April 27, 2017 7:00 am to 9:00 am
Topic(s): Cerebrovascular Disease and Interventional Neurology
Director(s): Antonio Culebras MD, FAAN, FAHA
Description: With the accumulation of mounting experience, the frontiers of mechanical thrombectomy are in expansion fueled by robust data from recent clinical trials. The 6-6-6 rule (NIHSS minimum 6; onset 6 hours or less; ASPECTS 6 or higher) has become convention. The optimal neuroimaging modality remains under question and there are clinical variations such as very old age, wake-up-stroke, pregnancy, and others that require further exploration. Violation of parameters may lead to the reperfusion syndrome, a serious complication of excessive intervention. PFO is a common finding in patients with acute stroke. When PFO is associated with other vascular risk factors including a right-to-left shunt, uncertainties regarding prevention of recurrent stroke become a disquieting issue. Faculty will present a challenging case, discuss recommendations and present scientific evidence supporting recommendations to implement optimal acute Stroke Team Action Therapy (STAT).
Completion Message: Participants should become familiar with the expanding frontiers of mechanical thrombectomy in acute stroke and learn about the new guidelines for prevention of recurrent stroke in patients with PFO.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge

Program Speakers - Tentative

Start/End Time Title Faculty
7:00 AM - 7:05 AM Introduction Antonio Culebras MD, FAAN, FAHA 
7:05 AM - 8:00 AM Frontiers of Mechanical Thrombectomy in Acute Stroke Hesham Masoud MD 
8:00 AM - 9:00 AM Therapeutic Management of Recurrent Stroke in Patients with PFO and Additional Vascular Risk Factors Steven Messe MD, FAAN, FAHA 


Speaker Disclosure
Antonio Culebras, MD, FAAN, FAHA Dr. Culebras received personal compensation in an editorial capacity for Medlink and UpToDate.

Hesham Masoud, MD Dr. Masoud has nothing to disclose.

Steven R. Messe, MD, FAAN, FAHA Dr. Messe has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Claret Medical, Inc. Dr. Messe has received research support from WL Gore & Associates, Bayer, Mallinkrodt..

Register Now

Related Courses

Saturday April 21, 2018

1:30 PM-3:30 PM
C21 Stroke in Young Adults and Women Aneesh Singhal MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C29 Controversies in Stroke Treatment and Prevention Steven Messe MD, FAAN, FAHA

Monday April 23, 2018

7:00 AM-9:00 AM
C64 Update on Medical Management of Stroke Natalia Rost MD, MPH, FAAN
1:00 PM-3:00 PM
C75 Therapeutic Temperature Modulation in the ICU Stephan Mayer MD

Tuesday April 24, 2018

1:00 PM-3:00 PM
C114 Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
3:30 PM-5:30 PM
C128 Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Philip Gorelick MD, MPH, FAAN

Wednesday April 25, 2018

1:00 PM-3:00 PM
C150 Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Philip Gorelick MD, MPH, FAAN
3:30 PM-5:30 PM
C165 Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD

Thursday April 26, 2018

1:00 PM-3:00 PM
C194 Spanish: Update on Stroke Therapy Carlos Kase MD, FAAN, FAHA
3:30 PM-5:30 PM
C202 Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN

Friday April 27, 2018

7:00 AM-9:00 AM
C216 Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Seemant Chaturvedi MD, FAAN, FAHA


Forgot Password?